Larvol Delta - Nature-Aging-publishes-phase-II-results-for-AADvac1-a-firstinman-Alzheimers-tau-vaccine-developed-by-Axon-Neuroscience

AADvac1 - Axon Neurosci

https://www.prnewswire.com/news-releases/nature-aging-publishes-phase-ii-results-for-aadvac1-a-first-in-man-alzheimers-tau-vaccine-developed-by-axon-neuroscience-301311724.html

Jun 14, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next